Evaluation of epithelial proliferation in paediatric and adult cholesteatomas using the Ki-67 proliferation marker

被引:12
|
作者
Sikka, K. [1 ]
Sharma, S. C. [1 ]
Thakar, A. [1 ]
Dattagupta, S. [2 ]
机构
[1] All India Inst Med Sci, Dept Otorhinolaryngol Head & Neck Surg, New Delhi 110029, India
[2] All India Inst Med Sci, Dept Pathol, New Delhi 110029, India
来源
JOURNAL OF LARYNGOLOGY AND OTOLOGY | 2012年 / 126卷 / 05期
关键词
Cholesteatoma; Child; Cellular Proliferation; Pathology; MIDDLE-EAR CHOLESTEATOMA; NUCLEAR ANTIGEN; MEATAL SKIN; CELL; QUANTIFICATION; CHILDREN; MIB-1;
D O I
10.1017/S002221511100315X
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Introduction: The aggressiveness of cholesteatoma in children compared with adults is well known. However, the factors influencing the poorer prognosis of paediatric cholesteatoma are not well understood. This study compared the proliferative potential of paediatric cholesteatoma with that of adult cholesteatoma, using Ki-67 as a proliferation marker. Methods: A prospective study of 67 patients with aural cholesteatoma was performed. Thirty-eight adult and 29 paediatric cases were evaluated using clinical parameters including bone erosion, complications and extent of disease. A surgical specimen underwent histological evaluation and measurement of the proliferation index using Ki-67 labelling. Normal epithelium from a control group was also examined. Results: Cholesteatoma epithelium has a greater rate of proliferation than normal skin. There were however no statistical differences between the paediatric and adult cholesteatoma groups in terms of clinical behaviour or proliferation potential. Paediatric cholesteatoma was similar to adult cholesteatoma in terms of complications, bone erosion and disease spread. Conclusion: Cholesteatoma is a disorder of epithelial proliferation. Although postulated to be more aggressive in children than adults, this study found no clinicopathological differences between paediatric and adult cases.
引用
收藏
页码:460 / 463
页数:4
相关论文
共 50 条
  • [1] Ki-67, a marker of proliferation.
    Guinebretiere, JM
    Sabourin, JC
    ANNALES DE PATHOLOGIE, 1997, 17 (01) : 25 - 30
  • [2] Evaluation of the proliferation marker Ki-67 and the IDH mutation in glioblastoma
    Houssaini, Asmae Squalli
    Lamrabet, Salma
    Senhaji, Nadia
    Sekal, Mohammed
    Karkouri, Mehdi
    Bennis, Sanae
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 263 - 264
  • [3] Evaluation of the proliferation marker Ki-67 in a large prostatectomy cohort
    Richardsen, Elin
    Andersen, Sigve
    Al-Saad, Samer
    Rakaee, Mehrdad
    Nordby, Yngve
    Pedersen, Mona Irene
    Ness, Nora
    Grindstad, Thea
    Movik, Ingeborg
    Donnem, Tom
    Bremnes, Roy
    Busund, Lill-Tove
    PLOS ONE, 2017, 12 (11):
  • [4] Ki-67: more than a proliferation marker
    Sun, Xiaoming
    Kaufman, Paul D.
    CHROMOSOMA, 2018, 127 (02) : 175 - 186
  • [5] Ki-67 protein as a tumour proliferation marker
    Menon, Sunil Sankunny
    Guruvayoorappan, Chandrasekharan
    Sakthivel, Kunnathur Murugesan
    Rasmi, Rajan Radha
    CLINICA CHIMICA ACTA, 2019, 491 : 39 - 45
  • [6] Ki-67: more than a proliferation marker
    Xiaoming Sun
    Paul D. Kaufman
    Chromosoma, 2018, 127 : 175 - 186
  • [7] MONOCLONAL-ANTIBODY KI-67 AS A PROLIFERATION MARKER
    NEUBAUER, A
    HUHN, D
    BRITISH JOURNAL OF HAEMATOLOGY, 1987, 67 (04) : 495 - 495
  • [8] Proliferation marker Ki-67 in early breast cancer
    Urruticoechea, A
    Smith, IE
    Dowsett, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (28) : 7212 - 7220
  • [9] KI-67 NUCLEAR PROLIFERATION MARKER IN COLONIC POLYPS
    HARLAMERT, HA
    MILLER, MA
    FENOGLIOPREISER, CM
    LABORATORY INVESTIGATION, 1995, 72 (01) : A62 - A62
  • [10] Positivity of the proliferation marker Ki-67 in noncycling cells
    van Oijen, MGCT
    Medema, RH
    Slootweg, PJ
    Rijksen, G
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1998, 110 (01) : 24 - 31